pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 11·1 min read
save

Colombian court upholds compulsory license for HIV drug, affirming legal framework

May 11, 2026·read at STAT ↗RegulatoryPositive

The Court of Justice of the Andean Community ruled that Colombia's issuance of a compulsory license for an HIV medicine two years ago was lawful.

The tribunal said the government had a valid public interest justification and set an appropriate expiration date, meeting Andean regulations.

Consumer advocates hailed the decision as historic, noting its potential impact on medicine access across the region.

The ruling confirms that compulsory licensing remains a viable tool for governments to address public health needs, providing a precedent for future cases.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Colombia wins a key court ruling over a compulsory license issued for an HIV medicine”

read at STAT ↗
523 words · retrieved May 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
SanofiViiV Healthcare Company
topics
Duchenne Muscular Dystrophy

related stories

  • 1d agoGenmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, moreBioSpace
  • Aug 28Opinion: We quit the CDC last year. The problems we protested remainSTAT
  • Aug 14Capricor shares spike on CEO comments; Cytokinetics sues Bristol MyersBioPharma Dive
  • Jul 29Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, moreBioSpace
  • Jul 28STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATDSTAT